In a filing, Dynavax Technologies Corp revealed its Director Myers Scott Dunseth acquired Company’s shares for reported $41116.0 on Aug 22 ’25. In the deal valued at $10.82 per share,3,800 shares were bought. As a result of this transaction, Myers Scott Dunseth now holds 35,004 shares worth roughly $0.4 million.
Then, Deep Track Biotechnology Maste sold 1,094,994 shares, generating $12,077,784 in total proceeds. Upon selling the shares at $11.03, the 10% Owner now owns 16,696,492 shares.
Before that, Deep Track Biotechnology Maste sold 970,143 shares. Dynavax Technologies Corp shares valued at $10,273,814 were divested by the 10% Owner at a price of $10.59 per share. As a result of the transaction, Deep Track Biotechnology Maste now holds 15,726,349 shares, worth roughly $178.81 million.
Goldman downgraded its Dynavax Technologies Corp [DVAX] rating to a Sell from a a Neutral in a research note published on February 11, 2025; the price target was decreased to $12 from $15. A number of analysts have revised their coverage, including Goldman’s analysts, who began to cover the stock in early February with a ‘”a Neutral”‘ rating. JMP Securities began covering DVAX with “Mkt outperform” recommendation on September 27, 2022.
Price Performance Review of DVAX
On Friday, Dynavax Technologies Corp [NASDAQ:DVAX] saw its stock fall -0.52% to $11.37. Over the last five days, the stock has gained 5.28%. Dynavax Technologies Corp shares have fallen nearly -8.97% since the year began. Nevertheless, the stocks have fallen -10.96% over the past one year. While a 52-week high of $14.63 was reached on 03/07/25, a 52-week low of $9.20 was recorded on 09/15/25.
Levels Of Support And Resistance For DVAX Stock
The 24-hour chart illustrates a support level at 11.31, which if violated will result in even more drops to 11.25. On the upside, there is a resistance level at 11.46. A further resistance level may holdings at 11.55.
How much short interest is there in Dynavax Technologies Corp?
A steep rise in short interest was recorded in Dynavax Technologies Corp stocks on 2025-11-14, dropping by -0.48 million shares to a total of 13.72 million shares. Yahoo Finance data shows the prior-month short interest on 2025-10-15 was 14.2 million shares. There was a decline of -3.47%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on August 06, 2021 when Goldman began covering the stock and recommended ‘”a Buy”‘ rating along with a $19 price target.
